Skip to main content

. 1959 Oct;34(177):422–425. doi: 10.1136/adc.34.177.422

The Relationship between Decreased 5-Hydroxyindole Metabolism and Mental Defect in Phenylketonuria

C M B Pare, M Sandler, R S Stacey

PMCID: PMC2012407 PMID: 14430380

422

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ARMSTRONG M. D., McMILLAN A., SHAW K. N. 3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine. Biochim Biophys Acta. 1957 Aug;25(2):422–423. doi: 10.1016/0006-3002(57)90491-2. [DOI] [PubMed] [Google Scholar]
BLASCHKO H. Amine oxidase and amine metabolism. Pharmacol Rev. 1952 Dec;4(4):415–458. [PubMed] [Google Scholar]
BORN G. V., INGRAM G. I., STACEY R. S. The relationship between 5-hydroxytryptamine and adenosine triphosphate in blood platelets. Br J Pharmacol Chemother. 1958 Mar;13(1):62–64. doi: 10.1111/j.1476-5381.1958.tb00191.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
CAWTE J. E. Phenylketonuria. Med J Aust. 1954 Jul 3;2(1):15–19. [PubMed] [Google Scholar]
DAVISON A. N. Physiological role of monoamine oxidase. Physiol Rev. 1958 Oct;38(4):729–747. doi: 10.1152/physrev.1958.38.4.729. [DOI] [PubMed] [Google Scholar]
DAVISON A. N., SANDLER M. Inhibition of 5-hydroxytryptophan decarboxylase by phenylalanine metabolites. Nature. 1958 Jan 18;181(4603):186–187. doi: 10.1038/181186b0. [DOI] [PubMed] [Google Scholar]
ELLIOTT K. A. gamma-Aminobutyric acid and factor I. Rev Can Biol. 1958 Sep;17(3):367–388. [PubMed] [Google Scholar]
FELLMAN J. H. Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia. Proc Soc Exp Biol Med. 1956 Dec;93(3):413–414. doi: 10.3181/00379727-93-22773. [DOI] [PubMed] [Google Scholar]
HARDISTY R. M., STACEY R. S. 5-Hydroxytryptamine in normal human platelets. J Physiol. 1955 Dec 29;130(3):711–720. doi: 10.1113/jphysiol.1955.sp005437. [DOI] [PMC free article] [PubMed] [Google Scholar]
McISAAC W. M., PAGE I. H. New metabolites of serotonin in carcinoid urine. Science. 1958 Sep 5;128(3323):537–537. doi: 10.1126/science.128.3323.537. [DOI] [PubMed] [Google Scholar]
PARE C. M., SANDLER M., STACEY R. S. 5-Hydroxytryptamine deficiency in phenylketonuria. Lancet. 1957 Mar 16;272(6968):551–553. doi: 10.1016/s0140-6736(57)90920-0. [DOI] [PubMed] [Google Scholar]
SANDLER M., CLOSE H. G. Biochemical effect of phenylacetic acid in a patient with 5-hydroxytryptophan-secreting carcinoid tumor. Lancet. 1959 Sep 12;2(7098):316–318. doi: 10.1016/s0140-6736(59)91358-3. [DOI] [PubMed] [Google Scholar]
SANDLER M., DAVIES A., RIMINGTON C. Effect of phenylacetic acid on the carcinoid syndrome. Lancet. 1959 Sep 12;2(7098):318–322. doi: 10.1016/s0140-6736(59)91359-5. [DOI] [PubMed] [Google Scholar]
WEIL-MALHERBE H. The concentration of adrenaline in human plasma and its relation to mental activity. J Ment Sci. 1955 Oct;101(425):733–755. doi: 10.1192/bjp.101.425.733. [DOI] [PubMed] [Google Scholar]
WESTERMANN E., BALZER H., KNELL J. Hemmung der Serotoninbildung durch alpha-Methyl-Dopa. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;234(3):194–205. [PubMed] [Google Scholar]

ACTIONS

RESOURCES